Professionals 218 Users Online

Pelvic Organ Prolapse Repair Market

Market Study on Pelvic Organ Prolapse Repair: Non-surgical Treatment Accounts for Over Two-thirds Market Share

Pelvic Organ Prolapse Repair Market Segmented By Treatment types such as Non-surgical and Surgical with Targeted organs in Bladder, Vagina, Uterus, Small Bowel and Rectum

Pelvic Organ Prolapse Repair Market Outlook (2023 to 2033)

Revenue generated by the global pelvic organ prolapse (POP) repair market reached US$ 406.3 million in 2022. The market is projected to expand at a CAGR of 4.6% and climb to a value of US$ 665.5 million by the end of 2033.

Pelvic reconstruction products are commonly used worldwide as vaginal sling devices. Minimally invasive techniques are utilized to insert vaginal slings into the urethra, helping to maintain its proper position and effectively treat conditions such as urinary incontinence, while also reducing procedure time. Until a viable substitute is accepted for widespread use by regulatory organizations like the U.S. Food and Drug Administration (FDA), the utilization of vaginal mesh and vaginal sling systems is anticipated to increase during the projected period, thus contributing to market growth.

  • Non-surgical treatment of pelvic organ prolapse occupied a market share of 67.5% in 2022.
  • Revenue from pelvic organ prolapse repair accounted for 3.8% share of the global urinary incontinence market in 2022.

Due to a rise in pelvic floor conditions among women such as vaginal prolapse, urinary incontinence, interstitial cystitis, and fistulae, demand for pelvic organ prolapse repair is projected to grow. The need for both surgical and non-surgical treatments is expected to rise significantly as the prevalence of these conditions in women rise.

  • According to a report published in February 2021 by the Office on Women's Health (OASH), U.S. Department of Health and Human Services, pelvic organ prolapse and urinary incontinence, which are pelvic floor disorders, affect approximately one in every five women, highlighting their common occurrence among the female population.
  • According to the 2019 Global Burden of Disease (GBD) database, which compiled data from 195 countries between 1990 and 2019, approximately 40% of the global female population is estimated to experience pelvic organ prolapse. This percentage is projected to increase as the population ages.

Traditional treatment methods are replaced by robotic surgeries that are minimally invasive and lead to faster recovery. The complications associated with the use of synthetic mesh in pelvic floor repair in certain women have stimulated research initiatives into the use of biomaterials and cell-based therapies. These technological advancements and innovations are anticipated to influence the pelvic organ prolapse repair market positively. Tissue engineering using several different cell lines, including fibroblasts, and adult stem cells, has been suggested for application within the pelvic floor area.

Increasing research and development efforts to improve the treatment options for pelvic organ prolapse repair while minimizing risks and side effects are predicted to pave the way for better treatment options for patients to ensure minimal to no discomfort.

Attribute Key Insights

Pelvic Organ Prolapse Repair Market Size (2023)

US$ 423.4 Million

Projected Market Value (2033)

US$ 665.5 Million

Global Market Growth Rate (2023 to 2033)

4.6% CAGR

Market Share of Top 5 Countries


Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Which Aspects are Driving the Growth of the Pelvic Organ Prolapse Repair Market?

Manufacturers’ Growing Emphasis on Development of Effective, Long-lasting, and Safe Treatment Options for Pelvic Organ Prolapse

It is essential to develop technically enhanced products to attract customers and acquire a competitive advantage. Manufacturers now are concentrating on making pelvic reconstructive devices more effective, long-lasting, and safe. This involves focusing on innovative materials, enhanced surgical methods, and minimally invasive techniques.

Transvaginal meshes are banned in several countries due to adverse events associated with them, such as mesh erosion. A newly developed disposable ring-shaped vaginal device has been designed to address the limitations of existing ring pessaries used for the non-surgical treatment of pelvic organ prolapse (POP). This device can be easily inserted into an applicator and removed using a string, providing an improved solution for managing POP.

Manufacturers are expanding their market reach by working with hospitals, clinics, and other healthcare organizations. This way, manufacturers are trying to enhance their reputation and gain access to more customers by collaborating with various authorities in the field of pelvic reconstruction. Clinical trials, which help produce important evidence to support the effectiveness of their products, are being facilitated by these partnerships as well.

For manufacturers, geographical expansions open up lucrative opportunities. Identifying regions with a high prevalence of pelvic floor complications and limited access to advanced treatment alternatives help them establish their presence. The development of region-specific advertising strategies and service infrastructures has the potential to drive increased market penetration.

Educating patients about pelvic floor conditions and possible treatments also contributes to the demand for associated treatment options. To educate patients about symptoms, diagnoses, and available treatments, manufacturers work with patient advocacy groups, healthcare institutions, and online platforms, thus creating demand for their products.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What are the Hindrances to the Demand Growth for POP Repair Treatments?

Stringent Regulations, Product Recalls, and Availability of Non-Surgical Treatment Options

Due to product recalls and bans by regulatory bodies around the world, there are fewer products related to pelvic reconstruction currently. Mesh erosion, infections, vaginal scarring, and a recurrence of urine incontinence are a few of the commonly reported side effects. Medical mesh complications have given rise to litigation against manufacturers across the globe and questions about its safety.

Authorities have scrutinized the use of mesh-based devices in POP repair because of reported issues. Regulations and standards for the manufacturing and utilization of mesh products have been strengthened by regulatory organizations, which has limited the availability and decreased usage in certain regions.

Certain POP patients benefit from non-surgical and conservative treatment methods such as pelvic floor exercises, pessaries, and physical therapy. These options might be favored by certain patients, particularly those looking for minimally invasive techniques, which affect the demand for surgical procedures.

Expansion of the pelvic organ prolapse repair market is also hampered by patients’ and healthcare workers' limited knowledge of POP conditions and available treatments. POP remains undiagnosed and untreated because of patients’ lack of awareness or their unwillingness to opt for treatment.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-wise Insights

What Makes the United States a Lucrative Market for Providers of Pelvic Organ Prolapse Repair Solutions?

“Increasing Prevalence of Pelvic Organ Prolapse among Women”

The United States accounted for 29.2% share of the global pelvic organ prolapse repair market in 2022.

A large number of women in the country suffer from pelvic organ prolapse (POP). The growing presence of manufacturers in the United States has contributed to market expansion. Established industry players such as Johnson & Johnson and Boston Scientific already have a strong foothold in the country.

How is Demand for Pelvic Organ Prolapse Repair Shaping Up in China?

“Increasing Investments in Healthcare Fueling Demand for Pelvic Organ Prolapse Repair Surgeries”

China held 7.9% share of the global market in the year 2022.

China has a huge population, which results in a sizable patient pool for POP repair surgeries. There is significant demand for treatment options due to the high prevalence of POP among women, especially in older age groups.

China has been making investments in infrastructure and cutting-edge medical technologies. Patients from within the country as well as from nearby nations are drawn to have POP repair procedures due to the accessibility of advanced facilities, skilled medical staff, and advanced surgical techniques. As the market expands, opportunities for manufacturers to enter the Chinese market open up.

What is the Demand Projection for Pelvic Organ Prolapse Repair Treatment in Germany?

“High Demand for Pelvic Organ Prolapse Repair Treatment Due to Robust Healthcare Infrastructure and Strong Emphasis on R&D”

Germany accounted for 6.4% share of the global market in 2022.

Germany places a great emphasis on research and development in the healthcare sector. The development of innovative technologies, surgical methods, and medical equipment for POP repair is made possible by manufacturers’ focus on innovation. The German market is expanding due to the easy availability of innovative products and techniques.

Strong partnerships and collaborations between healthcare providers and manufacturers are crucial to the market's expansion. German healthcare organizations frequently work with manufacturers on research and development and clinical trials, encouraging the introduction of innovative products.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Category-wise Insights

Which Treatment Option is Widely Adopted for Pelvic Organ Prolapse?

“Widespread Adoption of Non-surgical Treatment Due to Cost-effectiveness and Faster Recovery Times”

Non-surgical treatment occupied 67.5% share of the global market in 2022.

The risks and possible complications associated with surgical procedures for POP include infection, hemorrhage, mesh-related problems, organ injury, and recurrence of prolapse. Due to these concerns, many people can be reluctant to have surgery and instead opt to treat their disease non-surgically, which involves a lesser risk.

Exercises for the pelvic floor, physical therapy, and the use of pessaries are examples of non-invasive, non-surgical treatments for POP. This appeals to patients who prefer to try non-invasive alternatives before surgery. Compared to surgical procedures, non-surgical treatments typically have lower risks, faster recovery time, and less discomfort, owing to such factors, the non-surgical methods are therefore vastly opted for by patients.

Which Application-based Segment Accounts for High Revenue Generation?

“Growing Prevalence of Uterine Prolapse Among Women Driving Utilization of Pelvic Organ Prolapse Repair Treatment”

By application, the uterine prolapse segment accounted for 40.5% share of the global market in 2022.

Uterine prolapse is one of the most common types of POP. It occurs when the uterus descends into the vaginal canal or protrudes outside the body. The prevalence of uterine prolapse is significant, especially among women who have undergone childbirth and experienced hormonal changes or are postmenopausal. The high incidence of uterine prolapse contributes to its prominence in the POP repair market.

Competition Landscape

The pelvic organ prolapse repair industry is highly fragmented, with numerous competitors offering products and services locally. These businesses are using strategies such as enhanced research and development and expansion to meet patients’ demands and grow their customer base.

Some key developments in this regard include the following:

  • In October 2022, Coloplast introduced the Saffron Fixation System, which was designed for ease of use and reliability during pelvic floor reconstruction for patients with pelvic organ prolapse (POP).
  • In December 2021, Caldera Medical announced FDA approval of Desara® TVez for stress urinary incontinence.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the pelvic organ prolapse repair market, which are available in the full report.

Pelvic Organ Prolapse Repair Industry Report Scope

Attribute Details

Forecast Period

2023 to 2033

Historical Data Available for

2012 to 2022

Market Analysis

US$ Million for Value

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Benelux
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Türkiye
  • GCC Countries
  • Northern Africa
  • South Africa

Key Market Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Covered

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation (American Medical Systems Inc.)
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical
  • Medgyn Products, Inc.
  • CooperSurgical, Inc.
  • DIMA S.L.
  • Digitimer Ltd.
  • Bray Group Ltd.
  • Medesign Ingenieur-Consulting GmbH
  • Panpac Medical Corp.
  • Bioteque America Inc.
  • Bliss GVS Pharma
  • Panpac Medical Corporation
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments of Pelvic Organ Prolapse Repair Industry Research


  • Non-surgical
    • Pessary
    • Pelvic Floor Muscle Therapy
  • Surgical
    • Colpocleisis
    • Colporrhaphy
    • Sacrocolpopexy
    • Sacrohysteropexy
    • Uterosacral or Sacrospinous Ligament Fixation


  • Cystocele
  • Urethrocele
  • Enterocele
  • Uterine Prolapse
  • Posterior Vaginal Wall Prolapse (Dropped Rectum)

End User:

  • Hospitals
  • Specialized Clinics
  • Female Care Facilities


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

- Companies Covered in This Report -

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation (American Medical Systems Inc.)
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical
  • CooperSurgical, Inc.
  • DIMA S.L.
  • Digitimer Ltd
  • Bray Group Ltd,
  • medesign Ingenieur-Consulting GmbH
  • Panpac Medical Corp.
  • Bioteque America Inc.
  • Bliss GVS Pharma
  • Panpac Medical Corporation
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign

- Frequently Asked Questions -

The global pelvic organ prolapse repair market was valued at US$ 406.3 million in 2022.

Demand for pelvic organ prolapse repair treatments increased at 3.5% CAGR from 2012 to 2022.

The United States accounted for 29.2% share of the global market in 2022.

China held 7.9% share of the global POP repair market in 2022.

The non-surgical segment held a leading market share of 67.5% in 2022.

The United States, Germany, United Kingdom, China, and Japan together account for 54.6% market share.

The market is set to reach a valuation of US$ 665.5 million by the end of 2033.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate